Barkibu vs Abridge

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (39 vs 41)
Barkibu logo

Barkibu

EmergingPet Care

General

A Coruña Spain pet telemedicine + AI insurance (Munich Re) across 7 European countries at €50M turnover with 75K+ insured pets; BAI trained on 800K consultations with 80% retention competing with Agria for European pet health platform.

AI VisibilityBeta
Overall Score
D39
Category Rank
#464 of 1158
AI Consensus
88%
Trend
up
Per Platform
ChatGPT
40
Perplexity
40
Gemini
37

About

Barkibu is an A Coruña, Spain-based pet health and insurance platform — operating across seven European countries (Spain, Germany, France, Italy, Portugal, Greece, and Finland) with approximately €50 million in annual turnover and 75,000+ insured animals — providing pet owners with AI-powered veterinary triage, telemedicine consultations with licensed veterinarians, and comprehensive pet insurance underwritten by Munich Re that processes most claims automatically within minutes through proprietary AI. Barkibu's BAI (Barkibu Artificial Intelligence), trained on over 800,000 veterinary consultations, provides 24/7 symptom assessment for dogs and cats. The company projects reaching 125,000 insured pets by end of 2025 with an 80% customer retention rate, and won the EY Scale Up Award 2025 recognizing its exceptional growth trajectory. Founded in 2015 by Pablo Pazos, Patricia Seoane, Enrique Torres, Álvaro Gutiérrez, and María González; pivoted to AI-first model in 2018. Certified B Corporation.

Full profile
Abridge logo

Abridge

EmergingHealthcare

General

Pittsburgh ambient clinical AI (founded by cardiologist) at $5.3B valuation Jun 2025; $800M total ($300M a16z/Khosla Series E) deployed at UPMC 12K clinicians, Mayo Clinic, Johns Hopkins competing with Nuance DAX for physician documentation.

AI VisibilityBeta
Overall Score
C41
Category Rank
#777 of 1158
AI Consensus
50%
Trend
up
Per Platform
ChatGPT
35
Perplexity
49
Gemini
33

About

Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.

Full profile

AI Visibility Head-to-Head

39
Overall Score
41
#464
Category Rank
#777
88
AI Consensus
50
up
Trend
up
40
ChatGPT
35
40
Perplexity
49
37
Gemini
33
41
Claude
51
42
Grok
38

Key Details

Category
General
General
Tier
Emerging
Emerging
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.